SharonJShaMDMS(She/Her)

Neurology • Palo Alto, CA

Movement Disorder, Dementia & Geriatrics

Clinical Professor, Neurology & Neurological Sciences, Stanford University

Join to view full profile

Dr. Sha is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Sha's full profile

Already have an account?

Office
213 Quarry Rd
Palo Alto, CA 94304
Phone+1 650-723-6469

Fax+1 650-725-0390
Is this information wrong?

Summary

Dr. Sharon Sha is a neurologist in Palo Alto, CA and is affiliated with Stanford Health Care. She received her medical degree from Georgetown University School of Medicine and has been in practice 11 years. She specializes in movement disorder and dementia & geriatrics and is experienced in alzheimer's disease, lewy body dementia, ataxia, huntington disease, and geriatrics / dementia.

Education & Training

University of California (San Francisco)Fellowship, Behavioral Neurology, 2010 - 2013
Stanford Health Care-Sponsored Stanford UniversityResidency, Neurology, 2008 - 2010
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Neurology, 2007 - 2008
California Pacific Medical CenterInternship, Internal Medicine, 2006 - 2007
Georgetown University School of MedicineClass of 2006

Certifications & Licensure

CA State Medical License 2008 - 2026
American Board of Psychiatry and Neurology Neurology
United council of neurological sub specialtiesbehavioral neurology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012

Clinical Trials

Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort Start of enrollment: 2012 Jul 01
Recruiting
Evaluation of E2609 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (Study: E2609-A001-101 Amendment 02) Start of enrollment: 2012 Jul 01
Completed
Phase 1
Efficacy and Safety Trial of Verubecestat (MK-8931) in Participants With Prodromal Alzheimer's Disease (MK-8931-019) Start of enrollment: 2013 Nov 05
Terminated
Phase 3
The PLasma for Alzheimer SymptoM Amelioration (PLASMA) Study Start of enrollment: 2014 Sep 01
Completed
Not Applicable
221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease Start of enrollment: 2015 Sep 15
Terminated
Phase 3
A Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease Start of enrollment: 2015 Nov 30
Terminated
Phase 2, Phase 3
A Study Evaluating the Efficacy and Safety of Crenezumab Versus Placebo in Participants With Prodromal to Mild Alzheimer's Disease (AD). Start of enrollment: 2016 Mar 22
Terminated
Phase 3
A Study of CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease Start of enrollment: 2017 Aug 03
Terminated
Phase 2, Phase 3
A Study to Evaluate the Efficacy and Safety of Semorinemab in Patients With Prodromal to Mild Alzheimer's Disease Start of enrollment: 2017 Oct 04
Terminated
Phase 2
Phase 2 Study of BIIB092 in Participants With Early Alzheimer's Disease Start of enrollment: 2018 May 03
Terminated
Phase 2
Clinical Trial Readiness for SCA1 and SCA3 Start of enrollment: 2018 Aug 16
Active, not recruiting
Join now to see all

Publications & Presentations

PubMed

Post-translational modifications linked to preclinical Alzheimer's disease-related pathological and cognitive changes.
Olamide Abiose, Jarod Rutledge, Patricia Moran-Losada, Michael E Belloy, Edward N Wilson, Zihuai He, Alexandra N Trelle, Divya Channappa, America Romero, Jennifer Park...> ;Alzheimer's & Dementia. 2024 Mar 1
The Cerebellar Cognitive Affective/Schmahmann Syndrome Scale in Spinocerebellar Ataxias.
Selvadurai, L., Perlman, S., Ashizawa, T., Wilmot, G., Onyike, C., Rosenthal, L., Shakkottai, V., Paulson, H., Subramony, S., Bushara, K., Kuo, S., Dietiker, C., Gesch...> ;Cerebellum. 2024 Jan 2
1 citations
Baseline neuropsychiatric symptoms and psychotropic medication use midway through data collection of the Longitudinal Early-Onset Alzheimer's Disease Study (LEADS) coh...
Turner, R., Polsinelli, A., Wonderlin, R., Hammers, D., Garcia, A., Eloyan, A., Taurone, A., Thangarajah, M., Beckett, L., Gao, S., Wang, S., Kirby, K., Logan, P., Ais...> ;Alzheimer's & Dementia. 2023 Nov 1
Pathogenic variants in the Longitudinal Early-onset Alzheimer's Disease Study cohort.
Turner, R., Turner, R., Kelly N H Nudelman, Trever Jackson, Malia Rumbaugh, Ani Eloyan, Marco Abreu, Jeffrey L Dage, Casey Snoddy, Kelley M Faber, Tatiana Foroud, Dust...> ;Alzheimer's & Dementia. 2023 Nov 1
1 citations
White matter hyperintensities are higher among early-onset Alzheimer's disease participants than their cognitively normal and early-onset nonAD peers: Longitudinal Ear...
Turner, R., Eloyan, A., Thangarajah, M., An, N., Borowski, B., Reddy, A., Aisen, P., Dage, J., Foroud, T., Ghetti, B., Griffin, P., Hammers, D., Iaccarino, L., Jack, C...> ;Alzheimer's & Dementia. 2023 Nov 1
1 citations
Learning slopes in early-onset Alzheimer's disease.
Turner, R., Dustin B Hammers, Sára Nemes, Taylor Diedrich, Ani Eloyan, Kala Kirby, Paul Aisen, Joel Kramer, Kelly Nudelman, Tatiana Foroud, Malia Rumbaugh, Alireza Atr...> ;Alzheimer's & Dementia. 2023 Nov 1
1 citations
The Sporadic Early-onset Alzheimer's Disease Signature Of Atrophy: Preliminary Findings From The Longitudinal Early-onset Alzheimer's Disease Study (LEADS) Cohort.
Turner, R., Turner, R., Alexandra Touroutoglou, Yuta Katsumi, Michael Brickhouse, Alexander Zaitsev, Ryan Eckbo, Paul Aisen, Laurel Beckett, Jeffrey L Dage, Ani Eloyan...> ;Alzheimer's & Dementia. 2023 Nov 1
1 citations
Lewy Body Dementia: An Overview of Promising Therapeutics.
Irina A Skylar-Scott, Sharon J Sha> ;Current Neurology and Neuroscience Reports. 2023 Oct 1
1 citations
Sex and APOE ε4 carrier effects on atrophy, amyloid PET, and tau PET burden in early-onset Alzheimer's disease.
Sára Nemes, Paige E Logan, Mohit K Manchella, Nidhi S Mundada, Renaud La Joie, Angelina J Polsinelli, Dustin B Hammers, Robert A Koeppe, Tatiana M Foroud, Kelly N Nude...> ;Alzheimer's & Dementia. 2023 Nov 1
Cerebrospinal fluid biomarkers in the Longitudinal Early-onset Alzheimer's Disease Study.
Turner, R., Jeffrey L Dage, Ani Eloyan, Maryanne Thangarajah, Dustin B Hammers, Anne M Fagan, Julia D Gray, Suzanne E Schindler, Casey Snoddy, Kelly N H Nudelman, Kell...> ;Alzheimer's & Dementia. 2023 Nov 1
2 citations
The most valuable player or the tombstone: is tau the correct target to treat Alzheimer's disease?
Kyan Younes, Sharon J Sha> ;Brain. 2023 Jun 1
4 citations
Prediction of neuropathologic lesions from clinical data.
Thanaphong Phongpreecha, Brenna Cholerton, Syed Bukhari, Alan L Chang, Davide De Francesco, Melan Thuraiappah, Dana Godrich, Amalia Perna, Martin G Becker, Neal G Ravi...> ;Alzheimer's & Dementia. 2023 Jul 1
2 citations
Illusory Responses across the Lewy Body Disease Spectrum.
Marian Shahid, Ashley Rawls, Veronica Ramirez, Sephira Ryman, Veronica E Santini, Laurice Yang, Sharon J Sha, Jacob N Hall, Thomas J Montine, Amy Lin, Lu Tian, Victor ...> ;Annals of Neurology. 2023 Apr 1
13 citations
Performance of a fully-automated Lumipulse plasma phospho-tau181 assay for Alzheimer's disease.
Edward N Wilson, Christina B Young, Javier Ramos Benitez, Michelle S Swarovski, Igor Feinstein, Manu Vandijck, Yann Le Guen, Nandita M Kasireddy, Marian Shahid, Nicole...> ;Alzheimer's Research & Therapy. 2022 Nov 12
Large Collaborative Registries and Real-world Data to Manage Amyloid-Related Imaging Abnormalities-Reply.
Jacob N Hall, Sharon J Sha> ;JAMA Neurology. 2022 Jun 1
4 citations
Six Recurrent Amyloid-Related Imaging Abnormality Episodes in a Patient Treated With Aducanumab.
Jacob N. Hall, Elizabeth C. Mormino, Amanda Ng, Athanasia Boumis, Jennifer L. Gaudioso, Guido Davidzon, Sharon J. Sha> ;JAMA Neurology. 2021 Nov 8
16 citations
Association of CSF Biomarkers With Hippocampal-Dependent Memory in Preclinical Alzheimer Disease
Alexandra N. Trelle, Valerie A. Carr, Edward N. Wilson, Michelle S. Swarovski, Madison P Hunt, Tyler N. Toueg, Tammy Tran, Divya Channappa, Nicole K Corso, Monica K Th...> ;Neurology. 2021 Mar 9
14 citations
Fluid and Tissue Biomarkers of Lewy Body Dementia: Report of an LBDA Symposium.
Gregory D Scott, Moriah R Arnold, Thomas G Beach, Christopher H Gibbons, Anumantha G Kanthasamy, Russell M Lebovitz, Afina W Lemstra, Leslie M Shaw, Charlotte E Teunis...> ;Frontiers in Neurology. 2021 Jan 1
50 citations
Ultra-Low-DoseF-Florbetaben Amyloid PET Imaging Using Deep Learning with Multi-Contrast MRI Inputs.
Kevin T Chen, Enhao Gong, Fabiola Bezerra de Carvalho Macruz, Junshen Xu, Athanasia Boumis, Mehdi Khalighi, Kathleen L Poston, Sharon J Sha, Michael D Greicius, Elizab...> ;Radiology. 2020 Sep 1
36 citations
Tau PET imaging with 18F-PI-2620 in aging and neurodegenerative diseases
Elizabeth C. Mormino, Tyler N. Toueg, Carmen Azevedo, Jessica B. Castillo, Wanjia Guo, Ayesha Nadiadwala, Nicole K Corso, Jacob N. Hall, Audrey P. Fan, Alexandra N. Tr...> ;European Journal of Nuclear Medicine and Molecular Imaging. 2021 Jul 1
28 citations
Hippocampal and cortical mechanisms at retrieval explain variability in episodic remembering in older adults.
Alexandra N. Trelle, Valerie A. Carr, Scott A Guerin, Monica K Thieu, Manasi Jayakumar, Wanjia Guo, Ayesha Nadiadwala, Nicole K Corso, Madison P Hunt, Celia P Litovsky...> ;Elife. 2020 May 29
8 citations
Lewy Body Dementia Association's Research Centers of Excellence Program: Inaugural Meeting Proceedings.
Bethany Peterson, Melissa J. Armstrong, Douglas Galasko, James E. Galvin, Jennifer G. Goldman, David J. Irwin, Henry L. Paulson, Daniel I. Kaufer, James B. Leverenz, A...> ;Alzheimer's Research & Therapy. 2019 Mar 13
69 citations
Safety, Tolerability, and Feasibility of Young Plasma Infusion in the Plasma for Alzheimer Symptom Amelioration Study: A Randomized Clinical Trial.
Sharon J. Sha, Gayle K. Deutsch, Lu Tian, Kara Richardson, Maria L. Coburn, Jennifer L. Gaudioso, Tatiana Marcal, Ethan Solomon, Athanasia Boumis, Anthony Bet, Maarten...> ;JAMA Neurology. 2019 Jan 1
12 citations
Positive Attitudes and Therapeutic Misconception Around Hypothetical Clinical Trial Participation in the Huntington's Disease Community.
Kristina Cotter, Carly E. Siskind, Sharon J. Sha, Andrea Hanson-Kahn> ;Journal of Huntington's Disease. 2019 Jan 1
44 citations
Ultra-Low-DoseF-Florbetaben Amyloid PET Imaging Using Deep Learning with Multi-Contrast MRI Inputs.
Kevin T Chen, Enhao Gong, Fabiola Bezerra de Carvalho Macruz, Junshen Xu, Athanasia Boumis, Mehdi Khalighi, Kathleen L Poston, Sharon J Sha, Michael D Greicius, Elizab...> ;Radiology. 2019 Mar 1
Join now to see all

Journal Articles

Safety, Tolerability, and Feasibility of Young Plasma Infusion in the Plasma for Alzheimer Symptom Amelioration Study
Lu Tian, Gayle K Deutsch, Geoffrey A Kerchner, Sharon J Sha, JAMA